Atlas Trials

Study of NK012 and Carboplatin in Solid Tumors With Dose Expansion in Triple Negative Breast Cancer

Clinical trial NCT01238952 · COMPLETED

Trial details

NCT number
NCT01238952
Sponsor
Nippon Kayaku Co., Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Advanced Solid TumorsMetastatic Triple Negative Breast Cancer
Start date
2010-07-01
Primary completion
2010-11-01
Enrollment
4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.